Once in the body, the CAR T cells target and kill cancer cells that express the specific protein targeted by the CAR. CAR T cell therapy has been shown to be particularly effective in treating certain types of blood cancers, such as leukemia and lymphoma.
CAR T cell therapy is a complex and individualized treatment that requires significant preparation and monitoring. Patients must undergo a process called leukapheresis to collect T cells from their blood, and the modified CAR T cells must be carefully grown in the laboratory before they can be infused back into the patient.